A. Nephritis
B. Chronic hepatitis
C. Bleeding disorders
D. A & B
A. Nephritis
B. Chronic hepatitis
C. Bleeding disorders
D. A & B
A. codeine
B. Methadone
C. Alphaprodine
D. Pentazocine
A. Contraindicated
B. Low safety
C. Can be used safely
D. Not much use
A. Meprobamate
B. Pentobarbital
C. Trimethadione
D. Phenytoin
A. 10 to 20 percent
B. 20 to 30 percent
C. 40 to 50 percent
D. 60 to 70 percent
A. Phenobarbitone
B. Phenytoin
C. Diazepam
D. Carbemezie
A. Antibiotics
B. Salicylates
C. Barbiturates
D. Phenothiazines
A. Folic acid deficiency
B. Alzhiemer’s disease
C. Cushing’s syndrome
D. Vitamin C deficiency
A. Pentazocine and buprinorphine
B. Pentazocine shows withdrawal symptoms in opioid dependent patients
C. Partial agonists are free from classic opioid adverse effects
D. Ethomorphine is similar to pethidine chemically
A. D-tubocurarin
B. Diazepam
C. Beclofen
D. Mephensin